Hospital
Shandong Provincial Hospital山东第一医科大学附属省立医院（山东省立医院）
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Fudan University hospital rankings A++ General list, 2023
-
Published research 16 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 12 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Fudan University hospital rankings
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| General list | A++ | 2023 | Tier only; hospitals in the same tier are not ordered against each other | https://rank.cn-healthcare.com/fudan/national-general |
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 山东第一医科大学附属省立医院（山东省立医院）
- English name
- Shandong Provincial Hospital
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Also known as
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Published research
- Tertiary lymphoid structures guided opportunities and challenges for immunotherapy in early gastroesophageal junction cancer and low rectal cancer. Human vaccines & immunotherapeutics, 2026
- The intersection of colorectal cancer and cardiovascular disease: shared mechanisms and clinical implications. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
-
Breast cancer
Published research
- LRRC32 Mediates Resistance to Everolimus in Hormone Receptor-Positive, HER2-Negative Breast Cancer. Cancer management and research, 2026
- Brucea javanica Oil Emulsion Promotes Breast Cancer Cell Autophagy and Apoptosis by Regulating PAX6 mRNA Stability Through the hsa_circ_0001589/G3BP1 Axis. Clinical and experimental pharmacology & physiology, 2026
PubMed indexes 2 papers on this condition that name this hospital.
-
Lung cancer
Published research
- Efficacy and safety of omitting the clinical target volume in limited-stage small cell lung cancer: a large-scale multicenter real-world study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2026
- Serum small extracellular vesicle-associated snoRNA panel adds diagnostic value to CEA and CYFRA21-1 for non-small cell lung cancer: an exploratory single-center study. Frontiers in oncology, 2026
PubMed indexes 2 papers on this condition that name this hospital.
-
Liver cancer
Published research
- Preoperative prediction of hepatocellular carcinoma histological grade using MRI-based artificial intelligence models: A systematic review and meta-analysis. European journal of radiology, 2026
- 4D nucleome landscape reveals dissolution of bipartite active X chromosome in liver cancer development. Nature cell biology, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
-
Stomach cancer
Published research
- PAFAH1B3 promotes gastric cancer progression by enhancing E2F8-mediated transcriptional activation of VEGFA expression. Biochemical pharmacology, 2026
- Impact of time from diagnosis to endoscopic resection on clinical outcomes in early gastric cancer. Annals of medicine, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
-
Prostate cancer
Published research
- Water-exchange pharmacokinetic modeling improves DCE-MRI for ROI-based assessment of prostate lesions and of clinically significant prostate cancer. Magnetic resonance imaging, 2026
PubMed indexes 1 paper on this condition that names this hospital.
-
Thyroid cancer
Published research
- Retraction notice to “Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved” [Arch. Biochem. Biophys. 689 (2020) 108461]. Archives of biochemistry and biophysics, 2026
- Predicting unfavorable response to initial radioactive iodine therapy in differentiated thyroid cancer: an explainable machine learning and survival analysis approach. Frontiers in endocrinology, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Other hospitals in Jinan
Source & evidence
- Source URL
- https://rank.cn-healthcare.com/fudan/national-general
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24